“Democrats reached a deal on Tuesday to add a measure to control prescription drug costs to President Biden’s social safety net plan, agreeing to allow the government to negotiate prices for medications covered by Medicare, as the House moved closer to a vote on the sprawling bill,” the New York Times reports.
“The prescription drug deal is limited. Starting in 2023, negotiations could begin on what Senator Ron Wyden of Oregon called the most expensive drugs — treatments for cancer and rheumatoid arthritis, as well as anticoagulants. Most drugs would still be granted patent exclusivity for five years before negotiations could start, and more advanced drugs, called biologics, would be protected for 12 years.”
Importantly, Sen. Kyrsten Sinema (D-AZ) also announced that she supported the deal.
Save to Favorites